Pharmacokinetic Study in Patients Receiving Posaconazole Therapy in Taiwan

NCT02217761 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2014-08-15

No results posted yet for this study

Summary

The purpose of this study is to investigate the factors influencing pharmacokinetic and pharmacodynamic properties of new antifungal agent, posaconazole in Taiwanese patients.

Conditions

  • Pharmacokinetics
  • Posaconazole

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Shu-Wen Lin, Pharm. D. · Graduate institute of clinical pharmacy at National Taiwan University

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2017-07-31
Completion
2017-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02217761 on ClinicalTrials.gov